JIR
SGEN

James Investment Research’s Seagen Inc. Common Stock SGEN Stock Holding History

James Investment Research’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-108
Closed -$22K – 562
2023
Q1 		$22K Buy
+108
New +$17.3K ﹤0.01% 434
2020
Q3 		– Sell
-625
Closed -$106K – 521
2020
Q2 		$106K Hold
625
– – 0.01% 275
2020
Q1 		$72K Hold
625
– – 0.01% 280
2019
Q4 		$71K Buy
+625
New +$66.3K ﹤0.01% 356

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

James Investment Research's SGEN Position: Q2 2023 in Review

James Investment Research sold out of Seagen Inc. Common Stock (SGEN) in Q2 2023, closing a stake of 108 shares — an estimated $22K sold.

James Investment Research first reported a position in SGEN in Q4 2019 and held it in 4 quarters. The position peaked at $106K in Q2 2020. 596 funds tracked by Wall St. Rank hold SGEN as of Q2 2023.

  • James Investment Research reported no remaining Seagen Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 108 Seagen Inc. Common Stock shares in Q2 2023, an estimated $22K.
  • James Investment Research first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 4 quarters.
  • James Investment Research's Seagen Inc. Common Stock position peaked at $106K in Q2 2020.
  • 596 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.